Request an invite

Qalsody: which tox species, and why?

tofersen · SOD1 (ASO)
Species
Cynomolgus monkey (IT, relevant species), CD-1 mouse (SC) and rat single-dose IT
“From the PK point of view, the monkey was the most relevant species for non-clinical efficacy and safety studies.”
✓ VerifiedEMA assessment report, p. 38Source ↗
Why that species
Single base-pair mismatch to monkey SOD1 (likely active); all other species have >=4 mismatches
“Furthermore, a single base-pair mismatch to the Cynomolgus monkey gene suggests it may be active in NHPs, thereby enabling assessment of possible on-target effects, while wild-type animals of all other species appear not to be suitable due to at least four or more mismatches in the target sequence.”
✓ VerifiedEMA assessment report, p. 23Source ↗
Surrogate molecule
No surrogate; no rodent SOD1-targeting ASO identified; clinical ASO tested in all species
“No ASO specifically targeting rat and mouse SOD1 was used in toxicology studies, due to the lack of sequence homology of tofersen in rodents.”
✓ VerifiedEMA assessment report, p. 31Source ↗

Same question, other oligonucleotides

Amondys 45

casimersen · DMD exon 45 (PMO)
Adult male mouse and cynomolgus monkey; juvenile male rat

Amvuttra

vutrisiran · TTR (siRNA)
Rat and cynomolgus monkey (monkey only pharmacologically active; rat for off-target/class tox); rabbit EFD

Dawnzera

donidalorsen · Prekallikrein / KLKB1 (ASO)
Mouse (CD-1) and cynomolgus monkey

Exondys 51

eteplirsen · DMD exon 51 (PMO)
Cynomolgus monkey and juvenile rat (eteplirsen); mdx/C57BL mouse incl. mouse surrogate

Givlaari

givosiran · ALAS1 (siRNA)
Rat and cynomolgus monkey (both pharmacologically active); rabbit inactive (EFD only)

Izervay

avacincaptad pegol · C5 (aptamer)
Rabbit and dog (IVT ocular studies); rat and cynomolgus monkey (7-day IV); monkey the only pharmacologically relevant species

Kynamro

mipomersen · APOB (ASO)
Mouse, rat and cynomolgus monkey (clinical ASO plus rodent surrogates)

Leqvio

inclisiran · PCSK9 (siRNA)
Rat and cynomolgus monkey (both pharmacologically active); rabbit for EFD

Macugen

pegaptanib · VEGF-165 (aptamer)
Rabbit and dog (pivotal IVT); rat IV for systemic; supportive monkey, mouse

Onpattro

patisiran · TTR (siRNA)
Rat and cynomolgus monkey (monkey pharmacologically active; rat off-target/LNP)

Oxlumo

lumasiran · HAO1 (siRNA)
Rat and cynomolgus monkey (both pharmacologically relevant); rabbit for EFD

Qfitlia

fitusiran · Antithrombin / SERPINC1 (siRNA)
Healthy rat and cynomolgus monkey (GLP); hemophilia A mouse, hemophilia A dog and induced-HA monkey models

Redemplo

plozasiran · APOC3 (siRNA)
Rat (off-target toxicity) and cynomolgus monkey (pharmacologically relevant)

Rivfloza

nedosiran · LDHA (siRNA)
Cynomolgus monkey (relevant) plus mouse (nedosiran inactive; off-target assessment)

Rytelo

imetelstat · Telomerase (oligo)
Mouse and cynomolgus monkey (general tox); mouse and rabbit (EFD)

Spinraza

nusinersen · SMN2 (ASO)
Juvenile cynomolgus monkey (IT) and CD-1 mouse (SC, systemic effects)

Tegsedi

inotersen · TTR (ASO)
Mouse, rat and cynomolgus monkey; monkey the only pharmacologically relevant species

Tryngolza

olezarsen · APOC3 (ASO)
Mouse (with surrogate) and cynomolgus monkey

Viltepso

viltolarsen · DMD exon 53 (PMO)
Male CD-1 mouse and male cynomolgus monkey (plus juvenile male mouse)

Vyondys 53

golodirsen · DMD exon 53 (PMO)
Mouse, cynomolgus monkey (adult males) and juvenile rat

Wainua

eplontersen · TTR (ASO)
Mouse and cynomolgus monkey (monkey the pharmacologically relevant species)

Waylivra

volanesorsen · APOC3 (ASO)
Mouse, rat and cynomolgus monkey (rabbit for embryo-fetal); monkey most relevant

Zanvastro

zilganersen · GFAP (ASO)
Mouse (SC and ICV, juvenile) and juvenile monkey (intrathecal); mouse surrogate ASO arm

Summary across all 24 oligonucleotides →